
Evolution of systemic therapy of advanced hepatocellular carcinoma
Author(s) -
Ming Jiang,
Fei Liu,
Wu-Jun Xiong,
Li-Ye Zhong,
Ximei Chen
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.6546
Subject(s) - medicine , cirrhosis , gastroenterology , receiver operating characteristic , hepatocellular carcinoma , liver disease , model for end stage liver disease , area under the curve , sodium , stage (stratigraphy) , survival analysis , confidence interval , liver transplantation , transplantation , chemistry , paleontology , organic chemistry , biology
To investigate the prognostic value of the model for end-stage liver disease (MELD) and three new MELD-based models combination with serum sodium in decompensated cirrhosis patients-the MELD with the incorporation of serum sodium (MELD-Na), the integrated MELD (iMELD), and the MELD to sodium (MESO) index.